Mutahar Ahmed, MD
Urology · Maywood, NJNPI 1760451827
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.5% of it on its own, with 38 other manufacturers making up the rest. Among urology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 436 payments — averaging $949.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$296K
- Biotissue Holdings Inc.$70K
- Vascular Technology, Inc.$27K
- Amniox Medical, Inc.$8K
- Conmed Corporation$7K
- Johnson & Johnson$3K
- plus $3K from 33 others
Across 5 payments — averaging $10,000 each. An ownership or investment interest held by the physician or an immediate family member.
- New Wave Endo-surgical Corp.$50K
What the payments were for
- Consulting fees$83,87020%
- Speaking & faculty fees$49,05012%
- Travel & lodging$38,0699%
- Food & beverage$12,7173%
- Education$230,40056%
- Gifts$230%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 292 | $296,024 |
| Biotissue Holdings Inc. | 38 | $69,858 |
| Vascular Technology, Inc. | 5 | $27,230 |
| Amniox Medical, Inc. | 7 | $8,038 |
| Conmed Corporation | 5 | $7,400 |
| Johnson & Johnson(3 entities) | 19 | $2,522 |
| EDAP Technomed Inc | 4 | $520 |
| Coloplast | 5 | $479 |
| Boston Scientific | 9 | $441 |
| Procept Biorobotics Corporation | 3 | $300 |
| Royal Biologics, Inc. | 1 | $146 |
| Astellas Pharma US Inc | 6 | $141 |
| Teleflex LLC | 2 | $132 |
| Axonics, Inc. | 1 | $102 |
| Myovant Sciences Inc. | 5 | $72 |
| Davol Inc. | 1 | $51 |
| AstraZeneca | 2 | $51 |
| Acerus Pharmaceuticals Corporation | 1 | $49 |
| Laborie Medical Technologies Corp. | 1 | $49 |
| Urovant Sciences Inc | 3 | $44 |
| Tolmar Pharmaceuticals, Inc. | 3 | $42 |
| Medtronic | 1 | $42 |
| Ambu Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Janssen Scientific Affairs, LLC | 1 | $31 |
| Urogen Pharma, Inc. | 1 | $29 |
| Pfizer | 2 | $28 |
| Novartis | 1 | $26 |
| Metuchen Pharmaceuticals | 2 | $26 |
| AbbVie | 2 | $25 |
| Organogenesis Inc. | 1 | $22 |
| Kerecis Limited | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Olympus America Inc. | 1 | $18 |
| 180 Medical, Inc. | 1 | $17 |
| Bayer | 1 | $16 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $14 |
| Dendreon Pharmaceuticals LLC | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$270,813
- DA VINCI SP$23,104
- CLARIX$13,000
- NEOX$8,000
- AIRSEAL$7,380
- STRATAFIX$670
- Echelon Flex$319
- AquaBeam Robotic System$252
- VISTASEAL$226
- SURGICEL NU-KNIT$154
- Cryo-Cord$146
- ALTIS$136
- VISTASEAL Fibrin Sealant (Human)$125
- ECHELON ENDOPATH$125
- DERMABOND PRINEO$125
- GENERAL KIDNEY STONE DISEASE$120
- Barrigel$107
- Axonics$102
- Bulkamid$102
How this compares
$414,128 in reported general payments places this provider in the 95th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 49 | $48,858 |
| GemtesaVibegron | 23 | $19,846 |
| Solifenacin Succinate | 138 | $11,020 |
| Tamsulosin Hcl | 588 | $10,568 |
| AndrogelTestosterone | 13 | $9,163 |
| Finasteride | 530 | $8,272 |
| Silodosin | 33 | $3,363 |
| Dutasteride | 51 | $2,916 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 75 | $2,239 |
| Testosterone | 30 | $1,629 |
| Tadalafil | 44 | $1,570 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $823 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 41 | $816 |
| NitrofurantoinNitrofurantoin Macrocrystal | 19 | $647 |
| Oxybutynin Chloride ErOxybutynin Chloride | 16 | $617 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $141 | $48,85849 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $37 | $19,84623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 401 urology providers in New Jersey.
Other urology in Maywood
- Michael EspositoMaywood$28K
- Michael StifelmanHackensack$1.4M
- Gordon BrownCherry Hill$1.3M
- Thomas MuellerLinwood$1.1M
- David SussmanLinwood$802K
- Michael IngberDenville$530K
- Ravi MunverHackensack$529K
- Grannum SantBridgewater$487K
- Kevin GioiaRumson$143K
- Robert SimonCliffside Park$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.